Rameez Chatni, Global Director AI Solutions—Pharmaceutical and Life Sciences at Cloudera
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics…
Continue Reading
Seoul National University Hospital has recently unveiled a clinical decision support system for precision medicine treatment.WHY IT MATTERS
The SNUH POLARIS (Precision Oncology and Rare-Common Disease Supporter) is said to be the first of its…
For the 164th episode of the Healthcare IT Today Podcast, we are talking about 23andMe and privacy! We kick this episode off by discussing 23andMe's declaration of bankruptcy to theorize what we think this…
Continue Reading
Silicon Valley giant NVIDIA announced a partnership with the Arc Institute and Stanford University to launch a new foundation model, Evo 2, that understands the genetic code for all domains of life. The model, which…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics and precision health, today announced the launch of a new clinico-genomic dataset comprising over 15,000 patients treated with glucagon-like peptide-1 (GLP-1) agonists.
– These medications,…
Continue Reading
Top News
Several health systems launch the Truveta Genome Project, which will create a database of genotypic and phenotypic information. The data will be collected by using leftover biospecimens from the routine lab tests of…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics and precision health, and Komodo Health, a leader in healthcare technology and data-driven insights, are partnering to further enrich Helix’s clinico-genomic datasets within the Helix…
Continue Reading
Korea officially launches big bio data projectThe South Korean government has started recruiting participants for the National Integrated Bio Big Data Construction Project.
The ambitious 606 billion won (over $400 million) project is Korea’s largest healthcare project…
The mass rollout of AI-powered genomic health prediction (AIGHP) could pose significant risks concerning privacy and discrimination, a report by the Ada Lovelace Institute and the Nuffield Council on Bioethics (NCOB) has warned.
AIGHP refers…
Antidote Technologies, a digital patient engagement company, announced it is partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve trial timelines.Antidote offers a clinical trial patient recruitment…
Continue Reading
